Hepatorenal syndrome

Common Name(s)

Hepatorenal syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatorenal syndrome" returned 73 free, full-text research articles on human participants. First 3 results:

High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome.
 

Author(s): Jing-Bo Wang, Ye Gu, Ming-Xiang Zhang, Shun Yang, Yan Wang, Wei Wang, Xi-Ran Li, Yi-Tong Zhao, Hai-Tao Wang

Journal: World J. Gastroenterol.. 2018 Aug;24(29):3273-3280.

 

To detect the expression of type I inositol 1,4,5-trisphosphate receptor (IPRI) in the kidney of rats with hepatorenal syndrome (HRS).

Last Updated: 31 Dec 1969

Go To URL
Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of 'sterile inflammation' in patients with alcoholic cirrhosis and hepatorenal syndrome type II.
 

Author(s): Vanja P Nickovic, Dijana Miric, Bojana Kisic, Hristina Kocic, Marko Stojanovic, Salvatore Buttice, Gordana Kocic

Journal: Ren Fail. 2018 Nov;40(1):340-349.

 

Continuous intake of alcohol leads to liver cirrhosis because of imbalance of oxidative stress/antioxidative defense and chronic 'sterile inflammation'. Hepatorenal syndrome (HRS) is the most severe complication of liver cirrhosis. The aim of our study was to assess: (1) the oxidative ...

Last Updated: 31 Dec 1969

Go To URL
A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion.
 

Author(s): Hiroteru Kamimura, Takayuki Watanabe, Tomoyuki Sugano, Nao Nakajima, Junji Yokoyama, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Takashi Kato, Gen Watanabe, Satoshi Yamagiwa, Shuji Terai

Journal:

 

BACKGROUND Hepatorenal syndrome (HRS) is a reversible renal impairment that occurs in patients with acute liver failure and advanced liver cirrhosis. HRS is due to a renal vasoconstriction that results from extreme vasodilatation. It is therefore a functional disorder, not associated ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatorenal syndrome" returned 43 free, full-text review articles on human participants. First 3 results:

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
 

Author(s): Haiqing Wang, Aixiang Liu, Wentao Bo, Xielin Feng, Yong Hu

Journal: Medicine (Baltimore). 2018 Apr;97(16):e0431.

 

Hepatorenal syndrome is a fatal complication of advanced cirrhosis. Terlipressin is the most widely used treatment method, however, the therapy effects remain inconsonant. We aim to systematically assess the safety and efficacy of terlipressin for hepatorenal syndrome.

Last Updated: 31 Dec 1969

Go To URL
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
 

Author(s): F J Gifford, J R Morling, J A Fallowfield

Journal: Aliment. Pharmacol. Ther.. 2017 03;45(5):593-603.

 

Hepatorenal syndrome type 1 (HRS1) is a functional, rapidly progressive, potentially reversible form of acute kidney injury occurring in patients with cirrhosis. Characterised by intense renal arterial vasoconstriction, it carries a very poor prognosis. There is a significant unmet ...

Last Updated: 31 Dec 1969

Go To URL
 Hepatorenal syndrome: Current concepts related to diagnosis and management.
 

Author(s): Ángelo Zambam de Mattos, Angelo Alves de Mattos, Nahum Méndez-Sánchez

Journal: Ann Hepatol. ;15(4):474-81.

 

 Renal failure in cirrhotic patients is a very severe condition. Hepatorenal syndrome has the worst prognosis among all causes of kidney failure in such patients. Hepatorenal syndrome is diagnosed especially in cirrhotic patients with ascites who develop loss renal function, despite ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 21 Jun 2017

Go to URL
Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
 

Status: Recruiting

Condition Summary: Renal Impairment in Hepatorenal Syndrome

 

Last Updated: 6 Mar 2018

Go to URL
A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1
 

Status: Recruiting

Condition Summary: Hepatorenal Syndrome

 

Last Updated: 9 Aug 2018

Go to URL